Clinical Trial Update: Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing antiestrogen therapy to an aromatase inhibitor as adjuvant treatment after chemotherapy for breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Antiestrogen
• Aromatase inhibitor (Aromatase inhibitor)

Snippet

Sponsor: Japan Breast Cancer Research Network | Conditions: Breast Neoplasms | Phase 2 | Status: TERMINATED